Targeted inhibition of macrophage STING signaling alleviates inflammatory injury and ventricular remodeling in acute myocardial infarction
Acta Pharmaceutica Sinica B · 2025-08 · 15 (8) · 4030-4046
DOI: 10.1016/j.apsb.2025.06.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2025-08. Verfasst von Huan Yao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan Provincial Engineering Research Center of Innovative Re-Development of Famous Classical Formulas, Tianfu TCM Innovation Harbour, Chengdu Univ…. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Mitochondrial DNA (mtDNA) acts as a damage-associated molecular pattern to activate the stimulator of interferon genes (STING) signaling in macrophages, promoting tissue inflammation. However, its role in acute myocardial infarction (AMI) remains unclear. Macrophage-specific Sting1 knockout mice were used to validate STING's pathological role in AMI. Cardiac and liver mtDNA were used to activate macrophages in co-culture systems with cardiomyocytes to assess fibrosis and hypertrophy. Panaxatriol saponin (PTS) was tested for its ability to block mtDNA-driven macrophage activation and subsequent cardiomyocyte damage. STING-PTS binding ability was analyzed. AMI rats received PTS to evaluate its effects on myocardial inflammation and ventricular remodeling. In vivo, macrophage-specific Sting1 knockout reduced myocardial inflammation and injury after AMI. In vitro, mtDNA-activated macrophages induced cardiomyocyte fibrosis and hypertrophy through STING signaling. PTS suppressed mtDNA-driven macrophage activation by directly binding STING, thereby blocking inflammatory cascades. In AMI rats, PTS treatment attenuated acute inflammation and reversed ventricular remodeling. These findings establish the mtDNA-STING axis in macrophages as a critical driver of post-AMI inflammation and identify pharmacological STING inhibition with PTS as a promising therapeutic strategy. The study bridges genetic validation with translational applications, highlighting macrophage STING as a novel target for ischemic heart disease management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sichuan Provincial Engineering Research Center of Innovative Re-Development of Famous Classical Formulas, Tianfu TCM Innovation Harbour, Chengdu University of Traditional Chinese Medicine, Chengdu 611930, China.
- Sichuan Provincial Engineering Technology Research Center of Natural Small Molecule Drug, Tianfu TCM Innovation Harbour, Chengdu University of Traditional Chinese Medicine, Chengdu 611930, China.
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China.
- Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
- Sichuan Police College, Luzhou 646000, China.
- School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yao, H., He, Q., Wei, S., Xiang, L., Luo, Y., Huang, C., Liu, W., Zheng, C., Li, X., & Gao, Y. (2025). Targeted inhibition of macrophage STING signaling alleviates inflammatory injury and ventricular remodeling in acute myocardial infarction. Acta Pharmaceutica Sinica B, 15(8), 4030-4046. https://doi.org/10.1016/j.apsb.2025.06.014
Vancouver
Yao H, He Q, Wei S, Xiang L, Luo Y, Huang C, et al. Targeted inhibition of macrophage STING signaling alleviates inflammatory injury and ventricular remodeling in acute myocardial infarction. Acta Pharmaceutica Sinica B. 2025;15(8):4030-4046. doi:10.1016/j.apsb.2025.06.014
BibTeX
@article{Yao2025,
author = {Yao, Huan and He, Qingman and Wei, Shujun and Xiang, Li and Luo, Yuanyuan and Huang, Cong and Liu, Weiwei and Zheng, Chuan and Li, Xueping and Gao, Yongxiang},
title = {Targeted inhibition of macrophage STING signaling alleviates inflammatory injury and ventricular remodeling in acute myocardial infarction},
journal = {Acta Pharmaceutica Sinica B},
year = {2025},
volume = {15},
number = {8},
pages = {4030--4046},
doi = {10.1016/j.apsb.2025.06.014}
}
EUVIMED